Clinical research has shown that CCR2+ (CCL2 receptor) macrophages and monocytes are extremely active in the lung and are located in the central area of fibrosis of IPF patients, indicating that CCL2/CCR2 plays an important role in the pathogenesis of fibrosis [56]. The gene discussed is CCL2; the disease is fibrosis.